Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OBE2109 in rectovaginal endometriosis
2017-004043-21Phase 2Terminated
- Sponsor
- ObsEva SA
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of linzagolix in endometriosis, sponsored by ObsEva SA. Started Feb 2018; status: terminated.
02
Drugs
linzagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2017-004043-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004043-21.